Skip to main content

Table 2 Operative findings and postoperative outcomes in PSM model

From: Modified duct-to-mucosa versus conventional pancreaticoenterostomy for pancreaticoduodenectomy: a retrospective cohort study based on propensity score matching analysis

Operative time (min) Group A (n = 82) Group B (n = 82) P value
214.6 ± 28.5 229.8 ± 26.5 < 0.001
Pancreaticoenterostomy time (min) 9.3 ± 1.8 21.5 ± 2.8 < 0.001
Blood loss (ml) 314.4 ± 147.6 349.9 ± 132.4 0.107
Intra-operative blood transfusion (ml), n (%)
 None 44 (53.7) 27 (32.9) 0.025
 600 17 (20.7) 27 (32.9)
 > 600 21 (25.6) 28 (34.1)
Delayed gastric emptying, n (%) 4 (4.9) 9 (11.0) 0.148
ICU transfer, n (%) 4 (4.9) 6 (7.3) 0.514
Postoperative hospital stay (days) 15.1 ± 2.8 17.74 ± 4.9 0.008
Final diagnosis, n (%)
 Pancreatic cancer 42 (51.2) 33 (40.2) 0.158
 Bile duct cancer 7 (8.5) 7 (8.5) > 0.999
 Intraductal papillary mucinous neoplasm 8 (9.8) 9 (11.0) 0.798
 Vater’s papilla cancer 5 (6.1) 4 (4.9) 0.732
 Neuroendocrine tumor 4 (4.9) 6 (7.3) 0.514
 Metastasis from other organs 6 (7.3) 5 (6.1) 0.755
 GIST 1 (1.2) 3 (3.7) 0.620
 Chronic pancreatitis 1 (1.2) 6 (7.3) 0.053
 Solid pseudopapillary tumor 6 (7.3) 6 (7.3) > 0.999
 Duodenal cancer 2 (2.4) 3 (3.7) 0.650
  1. PSM propensity score matching